
0:00
4:34
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
D'autres épisodes de "Illumina Genomics Podcast"



Ne ratez aucun épisode de “Illumina Genomics Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








